Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-01 Purchase |
2022-03-01 5:58 pm |
Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer |
76,686 | $0.23 | $17,638 | 100,000 (Direct) |
View |
| 2022-02-04 Purchase |
2022-02-07 5:09 pm |
Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer |
23,314 | $0.23 | $5,362 | 23,314 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-12 Option Award |
2022-01-26 4:14 pm |
N/A 2032-01-11 |
Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 5:00 pm |
N/A 2031-02-04 |
Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2020-03-03 Option Award |
2020-08-05 09:12 am |
N/A 2030-08-02 |
Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer |
300,000 | $0 | 300,000 (Direct) |
View |